MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-86

  1. 25,351 Posts.
    lightbulb Created with Sketch. 1377
    The FDA are copping it from all directions and I can understand them being under extreme pressure
    to quickly tick a box to get some drug into the chemist shops against the normality of extensive
    trial protocols....I can understand their hesitancy....
    In reality, they only are asking for a bit more "proof (bad word) to give them the confidence
    to tick that box....
    They would have "canned" it if they had concerns, minor hiccup and deflating IMO..Nothing more...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.